| Dr Steven Michael Kreiger & Associates, Inc. | |
|
133 Main St, Wakefield, RI 02879-3511 | |
| (401) 782-8150 | |
| (401) 783-9710 |
| Full Name | Dr Steven Michael Kreiger & Associates, Inc. |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 133 Main St, Wakefield, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316247273 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | ODTG00464 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Steven Michael Kreiger & Associates, Inc. 133 Main St, Wakefield, RI 02879-3511 Ph: (401) 782-8150 | Dr Steven Michael Kreiger & Associates, Inc. 133 Main St, Wakefield, RI 02879-3511 Ph: (401) 782-8150 |
News Archive
Scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have demonstrated why certain immune cells chronically exposed to HIV shut down, and how they can be reactivated.
Although traditionally understood to induce death in cancer cells, researchers at The University of Texas MD Anderson Cancer Center have discovered that the DAPK1 protein is actually essential for growth in breast and other cancers with mutations in the TP53 gene. This discovery indicates DAPK1 may be a promising new therapeutic target for many of the most aggressive cancers.
Massachusetts General Hospital (MGH) investigators may have found a way to solve a problem that has plagued a group of drugs called ligand-mimicking integrin inhibitors, which have the potential to treat conditions ranging from heart attacks to cancer metastasis.
A new study in the Nov. 21 advance online edition of the journal Nature Neuroscience details the biological basis of this ability for rapid adaptation: neurons located at the beginning of the brain's sensory information pathway that change their level of simultaneous firing.
An examination of the treatment received by patients with myocardial infarction (heart attack) at 80 hospitals in Quebec indicates that those who received either primary percutaneous coronary intervention (PPCI; such as angioplasty) or fibrinolysis (administration of medication to dissolve blood clots) beyond the times recommended in international guidelines had a significantly increased risk of death within 30 days, along with an increased risk of the combined outcome of death or readmission for heart attack or heart failure at one year, according to a study in the June 2 issue of JAMA.
› Verified 5 days ago
Optometric Care Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 553 Kingstown Road, Wakefield, RI 02879 Phone: 401-782-2100 Fax: 401-782-2101 | |
Koch Eye Associates Llp Optometrist Medicare: Not Enrolled in Medicare Practice Location: 20 Hampton Way, Bldg 1a, Wakefield, RI 02879 Phone: 401-783-7009 Fax: 401-789-3909 | |
Nicole Fantoni, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 20 Hampton Way, Bldg#1a, Wakefield, RI 02879 Phone: 401-783-7009 Fax: 401-789-3909 | |
Steven M. Kreiger, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 133 Main St, Wakefield, RI 02879 Phone: 401-782-8150 Fax: 401-783-9710 | |
Paul S & D Patricia Koch Ptr Optometrist Medicare: Not Enrolled in Medicare Practice Location: 20 Hampton Way, Building #1a, Wakefield, RI 02879 Phone: 401-783-7009 | |
Mark Deresienski, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 20 Hampton Way, Bldg#1a, Wakefield, RI 02879 Phone: 401-783-7009 Fax: 401-789-3909 |